Table 2.
Treatment Responses by Modified RECIST Criteria
| Treatment Response | Ridaforolimus (N = 38) Number of Patients, n (%) |
|---|---|
| Complete Response | 0 (0) |
| Partial Response | 0 (0) |
| Stable Disease | 18 (47.4) |
| Progressive Disease | 5 (13.2) |
| Unable to Evaluate | 1 (2.6) |
| Not Assessed | 14 (36.8) |
Abbreviation: RECIST = Response Evaluation Criteria in Solid Tumors.